Vicki Jardine is an accomplished professional in clinical development, currently serving as the VP of Global Clinical Development at Ratio Therapeutics since August 2025. Prior to this role, Vicki was the VP of Clinical Development at ARTBIO, leading efforts to advance 212Pb radiotherapeutics from early development through to clinical trials. Vicki's extensive experience at Bayer, spanning from 2009 to 2023, includes key leadership positions overseeing clinical development programs for oncology radiotherapeutic agents, managing large teams across diverse therapeutic areas, and serving as the Global Medical Expert for pivotal Phase III studies. Vicki holds an MB PhD in Radiology and a BA in Neuroscience from the University of Cambridge.
This person is not in the org chart
This person is not in any teams
This person is not in any offices